STOK R&D to Revenue
Stoke Therapeutics Inc · R&D to Revenue
STOK R&D to Revenue
Latest reported74.79%period ending
STOK FY R&D/Revenue (0.00% → 74.79%)
Latest values, visible window
High-resolution chart · PNG
STOK r&d to revenue history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D to Revenue |
|---|---|
| 74.7869% | |
| 243.8326% | |
| 936.5718% | |
| 627.4647% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% |